[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hyperimmune Globulins Market Analysis and Forecast 2024-2030

April 2024 | 128 pages | ID: G8553B23A39DEN
APO Research

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. This is in contrast to vaccines that provide 'active' immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant 'passive' short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

According to APO Research, The global Hyperimmune Globulins market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.

Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.

In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

This report presents an overview of global market for Hyperimmune Globulins, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Hyperimmune Globulins, also provides the sales of main regions and countries. Of the upcoming market potential for Hyperimmune Globulins, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hyperimmune Globulins sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Hyperimmune Globulins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Hyperimmune Globulins sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc.

Hyperimmune Globulins segment by Company
  • CSL Behring
  • Grifols
  • Biotest
  • Kedrion
  • CBPO
  • Emergent (Cangene)
  • Kamada
  • CNBG
  • Hualan Bio
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang
  • ADMA Biologics
Hyperimmune Globulins segment by Type
  • Hepatitis B Immunoglobulins
  • Rabies Immunoglobulins
  • Tetanus Immunoglobulins
  • Rho(D) Immunoglobulins
  • Other
Hyperimmune Globulins segment by Application
  • Government Institutions
  • Private Sector
  • Other
Hyperimmune Globulins segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperimmune Globulins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hyperimmune Globulins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperimmune Globulins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hyperimmune Globulins in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hyperimmune Globulins manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hyperimmune Globulins sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Hyperimmune Globulins Market by Type
  1.2.1 Global Hyperimmune Globulins Market Size by Type, 2019 VS 2023 VS 2030
  1.2.2 Hepatitis B Immunoglobulins
  1.2.3 Rabies Immunoglobulins
  1.2.4 Tetanus Immunoglobulins
  1.2.5 Rho(D) Immunoglobulins
  1.2.6 Other
1.3 Hyperimmune Globulins Market by Application
  1.3.1 Global Hyperimmune Globulins Market Size by Application, 2019 VS 2023 VS 2030
  1.3.2 Government Institutions
  1.3.3 Private Sector
  1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives

2 HYPERIMMUNE GLOBULINS MARKET DYNAMICS

2.1 Hyperimmune Globulins Industry Trends
2.2 Hyperimmune Globulins Industry Drivers
2.3 Hyperimmune Globulins Industry Opportunities and Challenges
2.4 Hyperimmune Globulins Industry Restraints

3 GLOBAL MARKET GROWTH PROSPECTS

3.1 Global Hyperimmune Globulins Revenue Estimates and Forecasts (2019-2030)
3.2 Global Hyperimmune Globulins Revenue by Region
  3.2.1 Global Hyperimmune Globulins Revenue by Region: 2019 VS 2023 VS 2030
  3.2.2 Global Hyperimmune Globulins Revenue by Region (2019-2024)
  3.2.3 Global Hyperimmune Globulins Revenue by Region (2025-2030)
  3.2.4 Global Hyperimmune Globulins Revenue Market Share by Region (2019-2030)
3.3 Global Hyperimmune Globulins Sales Estimates and Forecasts 2019-2030
3.4 Global Hyperimmune Globulins Sales by Region
  3.4.1 Global Hyperimmune Globulins Sales by Region: 2019 VS 2023 VS 2030
  3.4.2 Global Hyperimmune Globulins Sales by Region (2019-2024)
  3.4.3 Global Hyperimmune Globulins Sales by Region (2025-2030)
  3.4.4 Global Hyperimmune Globulins Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America

4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS

4.1 Global Hyperimmune Globulins Revenue by Manufacturers
  4.1.1 Global Hyperimmune Globulins Revenue by Manufacturers (2019-2024)
  4.1.2 Global Hyperimmune Globulins Revenue Market Share by Manufacturers (2019-2024)
  4.1.3 Global Hyperimmune Globulins Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Hyperimmune Globulins Sales by Manufacturers
  4.2.1 Global Hyperimmune Globulins Sales by Manufacturers (2019-2024)
  4.2.2 Global Hyperimmune Globulins Sales Market Share by Manufacturers (2019-2024)
  4.2.3 Global Hyperimmune Globulins Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Hyperimmune Globulins Sales Price by Manufacturers (2019-2024)
4.4 Global Hyperimmune Globulins Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Hyperimmune Globulins Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Hyperimmune Globulins Manufacturers, Product Type & Application
4.7 Global Hyperimmune Globulins Manufacturers Commercialization Time
4.8 Market Competitive Analysis
  4.8.1 Global Hyperimmune Globulins Market CR5 and HHI
  4.8.2 2023 Hyperimmune Globulins Tier 1, Tier 2, and Tier

5 HYPERIMMUNE GLOBULINS MARKET BY TYPE

5.1 Global Hyperimmune Globulins Revenue by Type
  5.1.1 Global Hyperimmune Globulins Revenue by Type (2019 VS 2023 VS 2030)
  5.1.2 Global Hyperimmune Globulins Revenue by Type (2019-2030) & (US$ Million)
  5.1.3 Global Hyperimmune Globulins Revenue Market Share by Type (2019-2030)
5.2 Global Hyperimmune Globulins Sales by Type
  5.2.1 Global Hyperimmune Globulins Sales by Type (2019 VS 2023 VS 2030)
  5.2.2 Global Hyperimmune Globulins Sales by Type (2019-2030) & (K Units)
  5.2.3 Global Hyperimmune Globulins Sales Market Share by Type (2019-2030)
5.3 Global Hyperimmune Globulins Price by Type

6 HYPERIMMUNE GLOBULINS MARKET BY APPLICATION

6.1 Global Hyperimmune Globulins Revenue by Application
  6.1.1 Global Hyperimmune Globulins Revenue by Application (2019 VS 2023 VS 2030)
  6.1.2 Global Hyperimmune Globulins Revenue by Application (2019-2030) & (US$ Million)
  6.1.3 Global Hyperimmune Globulins Revenue Market Share by Application (2019-2030)
6.2 Global Hyperimmune Globulins Sales by Application
  6.2.1 Global Hyperimmune Globulins Sales by Application (2019 VS 2023 VS 2030)
  6.2.2 Global Hyperimmune Globulins Sales by Application (2019-2030) & (K Units)
  6.2.3 Global Hyperimmune Globulins Sales Market Share by Application (2019-2030)
6.3 Global Hyperimmune Globulins Price by Application

7 COMPANY PROFILES

7.1 CSL Behring
  7.1.1 CSL Behring Comapny Information
  7.1.2 CSL Behring Business Overview
  7.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.1.4 CSL Behring Hyperimmune Globulins Product Portfolio
  7.1.5 CSL Behring Recent Developments
7.2 Grifols
  7.2.1 Grifols Comapny Information
  7.2.2 Grifols Business Overview
  7.2.3 Grifols Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.2.4 Grifols Hyperimmune Globulins Product Portfolio
  7.2.5 Grifols Recent Developments
7.3 Biotest
  7.3.1 Biotest Comapny Information
  7.3.2 Biotest Business Overview
  7.3.3 Biotest Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.3.4 Biotest Hyperimmune Globulins Product Portfolio
  7.3.5 Biotest Recent Developments
7.4 Kedrion
  7.4.1 Kedrion Comapny Information
  7.4.2 Kedrion Business Overview
  7.4.3 Kedrion Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.4.4 Kedrion Hyperimmune Globulins Product Portfolio
  7.4.5 Kedrion Recent Developments
7.5 CBPO
  7.5.1 CBPO Comapny Information
  7.5.2 CBPO Business Overview
  7.5.3 CBPO Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.5.4 CBPO Hyperimmune Globulins Product Portfolio
  7.5.5 CBPO Recent Developments
7.6 Emergent (Cangene)
  7.6.1 Emergent (Cangene) Comapny Information
  7.6.2 Emergent (Cangene) Business Overview
  7.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.6.4 Emergent (Cangene) Hyperimmune Globulins Product Portfolio
  7.6.5 Emergent (Cangene) Recent Developments
7.7 Kamada
  7.7.1 Kamada Comapny Information
  7.7.2 Kamada Business Overview
  7.7.3 Kamada Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.7.4 Kamada Hyperimmune Globulins Product Portfolio
  7.7.5 Kamada Recent Developments
7.8 CNBG
  7.8.1 CNBG Comapny Information
  7.8.2 CNBG Business Overview
  7.8.3 CNBG Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.8.4 CNBG Hyperimmune Globulins Product Portfolio
  7.8.5 CNBG Recent Developments
7.9 Hualan Bio
  7.9.1 Hualan Bio Comapny Information
  7.9.2 Hualan Bio Business Overview
  7.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.9.4 Hualan Bio Hyperimmune Globulins Product Portfolio
  7.9.5 Hualan Bio Recent Developments
7.10 Shanghai RAAS
  7.10.1 Shanghai RAAS Comapny Information
  7.10.2 Shanghai RAAS Business Overview
  7.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.10.4 Shanghai RAAS Hyperimmune Globulins Product Portfolio
  7.10.5 Shanghai RAAS Recent Developments
7.11 Sichuan Yuanda Shuyang
  7.11.1 Sichuan Yuanda Shuyang Comapny Information
  7.11.2 Sichuan Yuanda Shuyang Business Overview
  7.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolio
  7.11.5 Sichuan Yuanda Shuyang Recent Developments
7.12 ADMA Biologics
  7.12.1 ADMA Biologics Comapny Information
  7.12.2 ADMA Biologics Business Overview
  7.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2019-2024)
  7.12.4 ADMA Biologics Hyperimmune Globulins Product Portfolio
  7.12.5 ADMA Biologics Recent Developments

8 NORTH AMERICA

8.1 North America Hyperimmune Globulins Market Size by Type
  8.1.1 North America Hyperimmune Globulins Revenue by Type (2019-2030)
  8.1.2 North America Hyperimmune Globulins Sales by Type (2019-2030)
  8.1.3 North America Hyperimmune Globulins Price by Type (2019-2030)
8.2 North America Hyperimmune Globulins Market Size by Application
  8.2.1 North America Hyperimmune Globulins Revenue by Application (2019-2030)
  8.2.2 North America Hyperimmune Globulins Sales by Application (2019-2030)
  8.2.3 North America Hyperimmune Globulins Price by Application (2019-2030)
8.3 North America Hyperimmune Globulins Market Size by Country
  8.3.1 North America Hyperimmune Globulins Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
  8.3.2 North America Hyperimmune Globulins Sales by Country (2019 VS 2023 VS 2030)
  8.3.3 North America Hyperimmune Globulins Price by Country (2019-2030)
  8.3.4 U.S.
  8.3.5 Canada

9 EUROPE

9.1 Europe Hyperimmune Globulins Market Size by Type
  9.1.1 Europe Hyperimmune Globulins Revenue by Type (2019-2030)
  9.1.2 Europe Hyperimmune Globulins Sales by Type (2019-2030)
  9.1.3 Europe Hyperimmune Globulins Price by Type (2019-2030)
9.2 Europe Hyperimmune Globulins Market Size by Application
  9.2.1 Europe Hyperimmune Globulins Revenue by Application (2019-2030)
  9.2.2 Europe Hyperimmune Globulins Sales by Application (2019-2030)
  9.2.3 Europe Hyperimmune Globulins Price by Application (2019-2030)
9.3 Europe Hyperimmune Globulins Market Size by Country
  9.3.1 Europe Hyperimmune Globulins Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
  9.3.2 Europe Hyperimmune Globulins Sales by Country (2019 VS 2023 VS 2030)
  9.3.3 Europe Hyperimmune Globulins Price by Country (2019-2030)
  9.3.4 Germany
  9.3.5 France
  9.3.6 U.K.
  9.3.7 Italy
  9.3.8 Russia

10 CHINA

10.1 China Hyperimmune Globulins Market Size by Type
  10.1.1 China Hyperimmune Globulins Revenue by Type (2019-2030)
  10.1.2 China Hyperimmune Globulins Sales by Type (2019-2030)
  10.1.3 China Hyperimmune Globulins Price by Type (2019-2030)
10.2 China Hyperimmune Globulins Market Size by Application
  10.2.1 China Hyperimmune Globulins Revenue by Application (2019-2030)
  10.2.2 China Hyperimmune Globulins Sales by Application (2019-2030)
  10.2.3 China Hyperimmune Globulins Price by Application (2019-2030)

11 ASIA (EXCLUDING CHINA)

11.1 Asia Hyperimmune Globulins Market Size by Type
  11.1.1 Asia Hyperimmune Globulins Revenue by Type (2019-2030)
  11.1.2 Asia Hyperimmune Globulins Sales by Type (2019-2030)
  11.1.3 Asia Hyperimmune Globulins Price by Type (2019-2030)
11.2 Asia Hyperimmune Globulins Market Size by Application
  11.2.1 Asia Hyperimmune Globulins Revenue by Application (2019-2030)
  11.2.2 Asia Hyperimmune Globulins Sales by Application (2019-2030)
  11.2.3 Asia Hyperimmune Globulins Price by Application (2019-2030)
11.3 Asia Hyperimmune Globulins Market Size by Country
  11.3.1 Asia Hyperimmune Globulins Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
  11.3.2 Asia Hyperimmune Globulins Sales by Country (2019 VS 2023 VS 2030)
  11.3.3 Asia Hyperimmune Globulins Price by Country (2019-2030)
  11.3.4 Japan
  11.3.5 South Korea
  11.3.6 India
  11.3.7 Australia
  11.3.8 China Taiwan
  11.3.9 Southeast Asia

12 MIDDLE EAST, AFRICA AND LATIN AMERICA

12.1 MEALA Hyperimmune Globulins Market Size by Type
  12.1.1 MEALA Hyperimmune Globulins Revenue by Type (2019-2030)
  12.1.2 MEALA Hyperimmune Globulins Sales by Type (2019-2030)
  12.1.3 MEALA Hyperimmune Globulins Price by Type (2019-2030)
12.2 MEALA Hyperimmune Globulins Market Size by Application
  12.2.1 MEALA Hyperimmune Globulins Revenue by Application (2019-2030)
  12.2.2 MEALA Hyperimmune Globulins Sales by Application (2019-2030)
  12.2.3 MEALA Hyperimmune Globulins Price by Application (2019-2030)
12.3 MEALA Hyperimmune Globulins Market Size by Country
  12.3.1 MEALA Hyperimmune Globulins Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
  12.3.2 MEALA Hyperimmune Globulins Sales by Country (2019 VS 2023 VS 2030)
  12.3.3 MEALA Hyperimmune Globulins Price by Country (2019-2030)
  12.3.4 Mexico
  12.3.5 Brazil
  12.3.6 Israel
  12.3.7 Argentina
  12.3.8 Colombia
  12.3.9 Turkey
  12.3.10 Saudi Arabia
  12.3.11 UAE

13 VALUE CHAIN AND SALES CHANNELS ANALYSIS

13.1 Hyperimmune Globulins Value Chain Analysis
  13.1.1 Hyperimmune Globulins Key Raw Materials
  13.1.2 Raw Materials Key Suppliers
  13.1.3 Manufacturing Cost Structure
  13.1.4 Hyperimmune Globulins Production Mode & Process
13.2 Hyperimmune Globulins Sales Channels Analysis
  13.2.1 Direct Comparison with Distribution Share
  13.2.2 Hyperimmune Globulins Distributors
  13.2.3 Hyperimmune Globulins Customers

14 CONCLUDING INSIGHTS

15 APPENDIX

15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
  15.5.1 Secondary Sources
  15.5.2 Primary Sources
15.6 Disclaimer


More Publications